Second Amendment to Loan Agreement, dated April 3, 2020, between registrant and Nikko Chemicals Co., Ltd

Contract Categories: Business Finance - Loan Agreements
EX-10.02 9 exhibit1002.htm EX-10.02 Document

Exhibit 10.02


SECOND AMENDMENT
TO LOAN AGREEMENT

THIS AMENDMENT TO AMENDMENT TO LOAN AGREEMENT (the “Second Amendment Agreement”), is made and entered into, as of April 3, 2020 (the “Effective Date”) by and between Nikko Chemicals Co., Ltd. (“Lender”) and Amyris, Inc. (“Borrower”). Except as otherwise defined herein, all capitalized terms in this Amendment have the same meaning as set forth in the Loan Agreement as amended by the First Amendment Agreement (as defined below).
WHEREAS, the parties hereto entered into a Loan Agreement dated December 19, 2019 (the “Loan Agreement”);
WHEREAS, the parties hereto entered into an Amendment to Loan Agreement dated March 12, 2020 (the “First Amendment Agreement”); and
WHEREAS, the parties hereto desire to confirm and amend certain terms of the Loan Agreement and the First Amendment Agreement.
NOW, THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are here acknowledged, the parties hereto hereby agree and confirm as follows:
1.  Payment. The repayment date of the Principal under Section 3(1) of the Loan Agreement shall be “April 30, 2020” (the “Maturity Date”), rather than March 31, 2020. Upon the execution of this Amendment, Borrower shall make an outstanding payment of all of the Interest under the Loan Agreement and the First Amendment Agreement which shall be US$55,718.74. Any Interest on the Second Amendment Agreement shall be payable on the Maturity Date. Notwithstanding above, all outstanding Loan and Interest shall be prepaid upon closing of the Borrower’s fundraising in the amount of $70,000,000.00 or more.

2.  Effective Date. This Agreement shall be effective as of the Effective Date (subject to Borrower’s full payment under Paragraph 4 to Lender). Except as expressly amended in this Agreement, any other terms and conditions shall remain unchanged and continue to be in full force and effect.





IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the date first above written.
 NIKKO CHEMICALS CO., LTD. 

 By: /s/ Shizuo Ukaji___________________
 
 Name: Shizuo Ukaji 
 Title: President & Chief Executive Officer 
  
  

AMYRIS, INC.
By: 
_/s/ John Melo_________________
Name: John Melo
Title: President & Chief Executive Officer